Company Filing History:
Years Active: 2014
Title: Zhida Sun: Innovator in HPV Vaccine Development
Introduction
Zhida Sun is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines against human papillomavirus (HPV). His innovative work focuses on identifying linear B-cell epitopes that can be utilized in vaccine formulations.
Latest Patents
Zhida Sun holds a patent titled "Minimal motifs of linear B-cell epitopes in L1 protein from human papillomavirus type 58 and their applications." This patent discloses eighteen linear epitope motifs and their extended 8-mer peptides in the L1 protein from HPV 58. These motifs can be used as antigens to specifically detect serum from subjects infected with HPV 58. Additionally, they can aid in the development of preventive or therapeutic multi-epitope peptide vaccines against HPV 58 by inducing humoral immunity. Among the eighteen B-cell epitope motifs, ten are 100% conservative, while one is highly conservative among many homologous proteins of high-risk HPVs. These motifs serve as candidate 'universal' epitopes for vaccine development.
Career Highlights
Zhida Sun is associated with Hengsun Pharmaceutical Technology Co. Ltd., where he continues to advance his research in HPV and vaccine technology. His work has the potential to significantly impact public health by providing effective preventive measures against HPV infections.
Collaborations
Zhida Sun collaborates with notable colleagues, including Wanxiang Xu and Shaohua Gu. Their combined expertise enhances the research and development efforts within their field.
Conclusion
Zhida Sun's innovative contributions to HPV vaccine development highlight his role as a key inventor in biotechnology. His work not only advances scientific knowledge but also holds promise for improving public health outcomes.